-
1
-
-
0027057483
-
Autologous versus allogeneic bone marrow transplantation for non-Hodgkin's lymphoma: A casecontrolled analysis of the European Bone Marrow Transplant Group Registry data
-
Chopra R, Goldstone AH, Pearce R, Philip T, Petersen F, Appelbaum F, et al. Autologous versus allogeneic bone marrow transplantation for non-Hodgkin's lymphoma: a casecontrolled analysis of the European Bone Marrow Transplant Group Registry data. J Clin Oncol. 1992;10(11):1690-5.
-
(1992)
J Clin Oncol.
, vol.10
, Issue.11
, pp. 1690-1695
-
-
Chopra, R.1
Goldstone, A.H.2
Pearce, R.3
Philip, T.4
Petersen, F.5
Appelbaum, F.6
-
2
-
-
0030831750
-
Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphoma
-
Verdonck LF, Dekker AW, Lokhorst HM, Petersen EJ, Nieuwenhuis HK. Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphoma. Blood. 1997;90 (10):4201-5.
-
(1997)
Blood
, vol.90
, Issue.10
, pp. 4201-4205
-
-
Verdonck, L.F.1
Dekker, A.W.2
Lokhorst, H.M.3
Petersen, E.J.4
Nieuwenhuis, H.K.5
-
3
-
-
34447339701
-
Long-term outcomes after reduced-intensity conditioning allogeneic stem cell transplantation for lowgrade lymphoma: A survey by the French Society of Bone Marrow Graft Transplantation and Cellular Therapy (SFGM-TC)
-
Vigouroux S, Michallet M, Porcher R, Attal M, Ades L, Bernard M, et al. Long-term outcomes after reduced-intensity conditioning allogeneic stem cell transplantation for lowgrade lymphoma: a survey by the French Society of Bone Marrow Graft Transplantation and Cellular Therapy (SFGM-TC). Haematologica. 2007;92(5): 627-34.
-
(2007)
Haematologica
, vol.92
, Issue.5
, pp. 627-634
-
-
Vigouroux, S.1
Michallet, M.2
Porcher, R.3
Attal, M.4
Ades, L.5
Bernard, M.6
-
4
-
-
34250223441
-
Pretransplant positive positron emission tomography/gallium scans predict poor outcome in patients with recurrent/refractory Hodgkin lymphoma
-
Jabbour E, Hosing C, Ayers G, Nunez R, Anderlini P, Pro B, et al. Pretransplant positive positron emission tomography/gallium scans predict poor outcome in patients with recurrent/refractory Hodgkin lymphoma. Cancer. 2007;109(12):2481-9.
-
(2007)
Cancer
, vol.109
, Issue.12
, pp. 2481-2489
-
-
Jabbour, E.1
Hosing, C.2
Ayers, G.3
Nunez, R.4
Anderlini, P.5
Pro, B.6
-
5
-
-
33845953927
-
Management of chronic lymphocytic leukemia: Practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation
-
Brugiatelli M, Bandini G, Barosi G, Lauria F, Liso V, Marchetti M, et al. Management of chronic lymphocytic leukemia: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation. Haematologica. 2006;91(12):1662-73.
-
(2006)
Haematologica
, vol.91
, Issue.12
, pp. 1662-1673
-
-
Brugiatelli, M.1
Bandini, G.2
Barosi, G.3
Lauria, F.4
Liso, V.5
Marchetti, M.6
-
6
-
-
33845543049
-
Indications for allogeneic stem cell transplantation in chronic lymphocytic leukemia: The EBMT transplant consensus
-
Dreger P, Corradini P, Kimby E, Michallet M, Milligan D, Schetelig J, et al. Indications for allogeneic stem cell transplantation in chronic lymphocytic leukemia: the EBMT transplant consensus. Leukemia. 2007;21(1):12-7.
-
(2007)
Leukemia
, vol.21
, Issue.1
, pp. 12-17
-
-
Dreger, P.1
Corradini, P.2
Kimby, E.3
Michallet, M.4
Milligan, D.5
Schetelig, J.6
-
7
-
-
33947318452
-
Hematopoietic cell transplantation for chronic lymphocytic leukemia: An evolving concept
-
Kharfan-Dabaja MA, Anasetti C, Santos ES. Hematopoietic cell transplantation for chronic lymphocytic leukemia: an evolving concept. Biol Blood Marrow Transplant. 2007;13(4):373-85.
-
(2007)
Biol Blood Marrow Transplant.
, vol.13
, Issue.4
, pp. 373-385
-
-
Kharfan-Dabaja, M.A.1
Anasetti, C.2
Santos, E.S.3
-
8
-
-
38649089434
-
Reducedintensity conditioning compared with conventional allogeneic stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma: An analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
-
Sureda A, Robinson S, Canals C, Carella AM, Boogaerts MA, Caballero D, et al. Reducedintensity conditioning compared with conventional allogeneic stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. J Clin Oncol. 2008;26(3): 455-62.
-
(2008)
J Clin Oncol.
, vol.26
, Issue.3
, pp. 455-462
-
-
Sureda, A.1
Robinson, S.2
Canals, C.3
Carella, A.M.4
Boogaerts, M.A.5
Caballero, D.6
-
9
-
-
79551631475
-
Autologous hematopoietic stem cell transplantation in chronic lymphocytic leukemia: Results of European intergroup randomized trial comparing autografting versus observation
-
Michallet M, Dreger P, Sutton L, Brand R, Richards S, van Os M, et al. Autologous hematopoietic stem cell transplantation in chronic lymphocytic leukemia: results of European intergroup randomized trial comparing autografting versus observation. Blood. 2011;117(5):1516-21.
-
(2011)
Blood
, vol.117
, Issue.5
, pp. 1516-1521
-
-
Michallet, M.1
Dreger, P.2
Sutton, L.3
Brand, R.4
Richards, S.5
van Os, M.6
-
10
-
-
84873567955
-
Long-term follow-up of reduced-intensity allogeneic stem cell transplantation for chronic lymphocytic leukemia: Prognostic model to predict outcome
-
Brown JR, Kim HT, Armand P, Cutler C, Fisher DC, Ho V, et al. Long-term follow-up of reduced-intensity allogeneic stem cell transplantation for chronic lymphocytic leukemia: prognostic model to predict outcome. Leukemia. 2013;27(2):362-9.
-
(2013)
Leukemia
, vol.27
, Issue.2
, pp. 362-369
-
-
Brown, J.R.1
Kim, H.T.2
Armand, P.3
Cutler, C.4
Fisher, D.C.5
Ho, V.6
-
11
-
-
0038702514
-
An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: Allogeneic transplantation is associated with a lower relapse rate but a higher procedurerelated mortality rate than autologous transplantation
-
Peniket AJ, Ruiz de Elvira MC, Taghipour G, Cordonnier C, Gluckman E, de Witte T, et al. An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedurerelated mortality rate than autologous transplantation. Bone Marrow Transplant. 2003;31(8):667-78.
-
(2003)
Bone Marrow Transplant.
, vol.31
, Issue.8
, pp. 667-678
-
-
Peniket, A.J.1
Ruiz de Elvira, M.C.2
Taghipour, G.3
Cordonnier, C.4
Gluckman, E.5
de Witte, T.6
-
12
-
-
0032774458
-
Allogeneic bone marrow transplant or second autograft in patients with acute leukemia who relapse after an autograft
-
Ringdén O, Labopin M, Frassoni F, Sanz G, Demeocq F, Prentice H, et al. Allogeneic bone marrow transplant or second autograft in patients with acute leukemia who relapse after an autograft. Bone Marrow Transplant. 1999;24(4):389-96.
-
(1999)
Bone Marrow Transplant.
, vol.24
, Issue.4
, pp. 389-396
-
-
Ringdén, O.1
Labopin, M.2
Frassoni, F.3
Sanz, G.4
Demeocq, F.5
Prentice, H.6
-
13
-
-
33747372635
-
Clinical outcome following autologous and allogeneic blood and marrow transplantation for relapsed diffuse large-cell non-Hodgkin's lymphoma
-
Aksentijevich I, Jones RJ, Ambinder RF, Garrett-Mayer E, Flinn IW. Clinical outcome following autologous and allogeneic blood and marrow transplantation for relapsed diffuse large-cell non-Hodgkin's lymphoma. Biol Blood Marrow Transplant. 2006;12(9): 965-72.
-
(2006)
Biol Blood Marrow Transplant.
, vol.12
, Issue.9
, pp. 965-972
-
-
Aksentijevich, I.1
Jones, R.J.2
Ambinder, R.F.3
Garrett-Mayer, E.4
Flinn, I.W.5
-
14
-
-
0031879197
-
Transplant-lite: Induction of graft-versusmalignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies
-
Khouri IF, Keating M, Körbling M, Przepiorka D, Anderlini P, O'Brien S, et al. Transplant-lite: induction of graft-versusmalignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies. J Clin Oncol. 1998;16(8):2817-24.
-
(1998)
J Clin Oncol.
, vol.16
, Issue.8
, pp. 2817-2824
-
-
Khouri, I.F.1
Keating, M.2
Körbling, M.3
Przepiorka, D.4
Anderlini, P.5
O'Brien, S.6
-
15
-
-
10244242523
-
Outcomes after alemtuzumab-containing reduced intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma
-
Morris E, Thomson K, Craddock C, Mahendra P, Milligan D, Cook G, et al. Outcomes after alemtuzumab-containing reduced intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma. Blood. 2004;104(13): 3865-71.
-
(2004)
Blood
, vol.104
, Issue.13
, pp. 3865-3871
-
-
Morris, E.1
Thomson, K.2
Craddock, C.3
Mahendra, P.4
Milligan, D.5
Cook, G.6
-
16
-
-
20544465644
-
Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia
-
Sorror ML, Maris MB, Sandmaier BM, Storer BE, Stuart MJ, Hegenbart U, et al. Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia. J Clin Oncol. 2005;23(16):3819-29.
-
(2005)
J Clin Oncol.
, vol.23
, Issue.16
, pp. 3819-3829
-
-
Sorror, M.L.1
Maris, M.B.2
Sandmaier, B.M.3
Storer, B.E.4
Stuart, M.J.5
Hegenbart, U.6
-
17
-
-
45149097052
-
Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab
-
Khouri IF, McLaughlin P, Saliba RM, Hosing C, Korbling M, Lee MS, et al. Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab. Blood. 2008;111(12):5530-6.
-
(2008)
Blood
, vol.111
, Issue.12
, pp. 5530-5536
-
-
Khouri, I.F.1
McLaughlin, P.2
Saliba, R.M.3
Hosing, C.4
Korbling, M.5
Lee, M.S.6
-
18
-
-
66149100443
-
Mature results of the M. D. Anderson Cancer Center riskadapted transplantation strategy in mantle cell lymphoma
-
Tam CS, Bassett R, Ledesma C, Korbling M, Alousi A, Hosing C, et al. Mature results of the M. D. Anderson Cancer Center riskadapted transplantation strategy in mantle cell lymphoma. Blood. 2009;113(18):4144-52.
-
(2009)
Blood.
, vol.113
, Issue.18
, pp. 4144-4152
-
-
Tam, C.S.1
Bassett, R.2
Ledesma, C.3
Korbling, M.4
Alousi, A.5
Hosing, C.6
-
19
-
-
80053901737
-
Nonmyeloablative allogeneic stem cell transplantation in relapsed/refractory chronic lymphocytic leukemia: Long-Term Follow-Up, Prognostic Factors, and Effect of Human Leukocyte Histocompatibility Antigen Subtype on Outcome
-
Khouri IF, Bassett R, Poindexter N, O'Brien S, Bueso-Ramos CE, Hsu Y, et al. Nonmyeloablative allogeneic stem cell transplantation in relapsed/refractory chronic lymphocytic leukemia: Long-Term Follow-Up, Prognostic Factors, and Effect of Human Leukocyte Histocompatibility Antigen Subtype on Outcome. Cancer. 2011;117(20):4679-88.
-
(2011)
Cancer
, vol.117
, Issue.20
, pp. 4679-4688
-
-
Khouri, I.F.1
Bassett, R.2
Poindexter, N.3
O'Brien, S.4
Bueso-Ramos, C.E.5
Hsu, Y.6
-
20
-
-
0242411675
-
Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma
-
van Besien K, Loberiza FR Jr, Bajorunaite R, Armitage JO, Bashey A, Burns LJ, et al. Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma. Blood. 2003;102(10): 3521-9.
-
(2003)
Blood
, vol.102
, Issue.10
, pp. 3521-3529
-
-
van Besien, K.1
Loberiza Jr., F.R.2
Bajorunaite, R.3
Armitage, J.O.4
Bashey, A.5
Burns, L.J.6
-
21
-
-
84856421828
-
Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin's lymphoma. Results of the HDR-ALLO study-a prospective clinical trial by the Grupo Español de Linfomas/Trasplante de Médula Osea (GEL/TAMO) and the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
-
Sureda A, Canals C, Arranz R, Caballero D, Ribera JM, Brune M, et al. Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin's lymphoma. Results of the HDR-ALLO study-a prospective clinical trial by the Grupo Español de Linfomas/Trasplante de Médula Osea (GEL/TAMO) and the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. Haematologica. 2012;97(2):310-7.
-
(2012)
Haematologica.
, vol.97
, Issue.2
, pp. 310-317
-
-
Sureda, A.1
Canals, C.2
Arranz, R.3
Caballero, D.4
Ribera, J.M.5
Brune, M.6
-
22
-
-
0037114621
-
Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: An analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation
-
Robinson SP, Goldstone AH, Mackinnon S, Carella A, Russell N, de Elvira CR, et al. Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation. Blood. 2002;100(13):4310-6.
-
(2002)
Blood
, vol.100
, Issue.13
, pp. 4310-4316
-
-
Robinson, S.P.1
Goldstone, A.H.2
McKinnon, S.3
Carella, A.4
Russell, N.5
de Elvira, C.R.6
-
23
-
-
0035895068
-
Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: Low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality
-
Khouri IF, Saliba RM, Giralt SA, Lee MS, Okoroji GJ, Hagemeister FB, et al. Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality. Blood. 2001;98 (13):3595-9.
-
(2001)
Blood
, vol.98
, Issue.13
, pp. 3595-3599
-
-
Khouri, I.F.1
Saliba, R.M.2
Giralt, S.A.3
Lee, M.S.4
Okoroji, G.J.5
Hagemeister, F.B.6
-
24
-
-
0036788483
-
Role of nonmyeloablative allogeneic stem-cell transplantation after failure of autologous transplantation in patients with lymphoproliferative malignancies
-
Branson K, Chopra R, Kottaridis PD, McQuaker G, Parker A, Schey S, et al. Role of nonmyeloablative allogeneic stem-cell transplantation after failure of autologous transplantation in patients with lymphoproliferative malignancies. J Clin Oncol. 2002;20(19):4022-31.
-
(2002)
J Clin Oncol.
, vol.20
, Issue.19
, pp. 4022-4031
-
-
Branson, K.1
Chopra, R.2
Kottaridis, P.D.3
McQuaker, G.4
Parker, A.5
Schey, S.6
-
25
-
-
0642368565
-
Nonablative allogeneic stem-cell transplantation for advanced/recurrent mantle-cell lymphoma
-
Khouri IF, Lee MS, Saliba RM, Jun G, Fayad L, Younes A, et al. Nonablative allogeneic stem-cell transplantation for advanced/recurrent mantle-cell lymphoma. J Clin Oncol. 2003;21(23):4407-12.
-
(2003)
J Clin Oncol.
, vol.21
, Issue.23
, pp. 4407-4412
-
-
Khouri, I.F.1
Lee, M.S.2
Saliba, R.M.3
Jun, G.4
Fayad, L.5
Younes, A.6
-
26
-
-
2942706076
-
Nonmyeloablative allogeneic hematopoietic transplantation: A promising salvage therapy for patients with non-Hodgkin's lymphoma whose disease has failed a prior autologous transplantation
-
Escalón MP, Champlin RE, Saliba RM, Acholonu SA, Hosing C, Fayad L, et al. Nonmyeloablative allogeneic hematopoietic transplantation: a promising salvage therapy for patients with non-Hodgkin's lymphoma whose disease has failed a prior autologous transplantation. J Clin Oncol. 2004;22(12): 2419-23.
-
(2004)
J Clin Oncol.
, vol.22
, Issue.12
, pp. 2419-2423
-
-
Escalón, M.P.1
Champlin, R.E.2
Saliba, R.M.3
Acholonu, S.A.4
Hosing, C.5
Fayad, L.6
-
27
-
-
38349114032
-
Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's lymphoma
-
Rezvani AR, Storer B, Maris M, Sorror ML, Agura E, Maziarz RT, et al. Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's lymphoma. J Clin Oncol. 2008;26(2):211-7.
-
(2008)
J Clin Oncol.
, vol.26
, Issue.2
, pp. 211-217
-
-
Rezvani, A.R.1
Storer, B.2
Maris, M.3
Sorror, M.L.4
Agura, E.5
Maziarz, R.T.6
-
28
-
-
9244219607
-
Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia
-
Rocha V, Labopin M, Sanz G, Arcese W, Schwerdtfeger R, Bosi A, et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med. 2004;351(22):2276-85.
-
(2004)
N Engl J Med.
, vol.351
, Issue.22
, pp. 2276-2285
-
-
Rocha, V.1
Labopin, M.2
Sanz, G.3
Arcese, W.4
Schwerdtfeger, R.5
Bosi, A.6
-
29
-
-
34249899377
-
Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: A comparison study
-
Eapen M, Rubinstein P, Zhang MJ, Stevens C, Kurtzberg J, Scaradavou A, et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet. 2007;369(9577): 1947-54.
-
(2007)
Lancet.
, vol.369
, Issue.9577
, pp. 1947-1954
-
-
Eapen, M.1
Rubinstein, P.2
Zhang, M.J.3
Stevens, C.4
Kurtzberg, J.5
Scaradavou, A.6
-
30
-
-
12144287126
-
Factors associated with outcomes of unrelated cord blood transplant: Guidelines for donor choice
-
Gluckman E, Rocha V, Arcese W, Michel G, Sanz G, Chan KW, et al. Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. Exp Hematol. 2004;32(4):397-407.
-
(2004)
Exp Hematol.
, vol.32
, Issue.4
, pp. 397-407
-
-
Gluckman, E.1
Rocha, V.2
Arcese, W.3
Michel, G.4
Sanz, G.5
Chan, K.W.6
-
31
-
-
29844452876
-
Clinical use of umbilical cord blood hematopoietic stem cells
-
Eurocord and European Blood and Marrow Transplant Group
-
Rocha V, Gluckman E; Eurocord and European Blood and Marrow Transplant Group. Clinical use of umbilical cord blood hematopoietic stem cells. Biol Blood Marrow Transplant. 2006;12(1 Suppl 1):34-41.
-
(2006)
Biol Blood Marrow Transplant.
, vol.12
, Issue.SUPPL. 1
, pp. 34-41
-
-
Rocha, V.1
Gluckman, E.2
-
32
-
-
9244256765
-
Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia
-
Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang MJ, Champlin RE, et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med. 2004;351 (22):2265-75.
-
(2004)
N Engl J Med.
, vol.351
, Issue.22
, pp. 2265-2275
-
-
Laughlin, M.J.1
Eapen, M.2
Rubinstein, P.3
Wagner, J.E.4
Zhang, M.J.5
Champlin, R.E.6
-
33
-
-
12844273651
-
Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy
-
Barker JN, Weisdorf DJ, DeFor TE, Blazar BR, McGlave PB, Miller JS, et al. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood. 2005;105(3):1343-7.
-
(2005)
Blood
, vol.105
, Issue.3
, pp. 1343-1347
-
-
Barker, J.N.1
Weisdorf, D.J.2
DeFor, T.E.3
Blazar, B.R.4
McGlave, P.B.5
Miller, J.S.6
-
34
-
-
33846007695
-
Double unrelated reduced-intensity umbilical cord blood transplantation in adults
-
Ballen KK, Spitzer TR, Yeap BY, McAfee S, Dey BR, Attar E, et al. Double unrelated reduced-intensity umbilical cord blood transplantation in adults. Biol Blood Marrow Transplant. 2007;13(1):82-9.
-
(2007)
Biol Blood Marrow Transplant.
, vol.13
, Issue.1
, pp. 82-89
-
-
Ballen, K.K.1
Spitzer, T.R.2
Yeap, B.Y.3
McAfee, S.4
Dey, B.R.5
Attar, E.6
-
35
-
-
58249087696
-
Analysis of risk factors for outcomes after unrelated cord blood transplantation in adults with lymphoid malignancies: A study by the Eurocord-Netcord and lymphoma working party of the European group for blood and marrow transplantation
-
Rodrigues CA, Sanz G, Brunstein CG, Sanz J, Wagner JE, Renaud M, et al. Analysis of risk factors for outcomes after unrelated cord blood transplantation in adults with lymphoid malignancies: a study by the Eurocord-Netcord and lymphoma working party of the European group for blood and marrow transplantation. J Clin Oncol. 2009;27(2):256-63.
-
(2009)
J Clin Oncol.
, vol.27
, Issue.2
, pp. 256-263
-
-
Rodrigues, C.A.1
Sanz, G.2
Brunstein, C.G.3
Sanz, J.4
Wagner, J.E.5
Renaud, M.6
-
36
-
-
0030925301
-
Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: Harnessing graft-versus-leukemia without myeloablative therapy
-
Giralt S, Estey E, Albitar M, van Besien K, Rondón G, Anderlini P, et al. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy. Blood. 1997;89 (12):4531-6.
-
(1997)
Blood
, vol.89
, Issue.12
, pp. 4531-4536
-
-
Giralt, S.1
Estey, E.2
Albitar, M.3
van Besien, K.4
Rondón, G.5
Anderlini, P.6
-
37
-
-
59349093509
-
Reduced-intensity conditioning regimen workshop: Defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research
-
Giralt S, Ballen K, Rizzo D, Bacigalupo A, Horowitz M, Pasquini M, Sandmaier B. Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research. Biol Blood Marrow Transplant. 2009;15(3):367-9.
-
(2009)
Biol Blood Marrow Transplant.
, vol.15
, Issue.3
, pp. 367-369
-
-
Giralt, S.1
Ballen, K.2
Rizzo, D.3
Bacigalupo, A.4
Horowitz, M.5
Pasquini, M.6
Sandmaier, B.7
-
38
-
-
70350764819
-
Defining the intensity of conditioning regimens: Working definitions
-
Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V, et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant. 2009; 15(12):1628-33.
-
(2009)
Biol Blood Marrow Transplant.
, vol.15
, Issue.12
, pp. 1628-1633
-
-
Bacigalupo, A.1
Ballen, K.2
Rizzo, D.3
Giralt, S.4
Lazarus, H.5
Ho, V.6
-
39
-
-
20144389145
-
Reduced-intensity unrelated cord blood transplantation for patients with advanced malignant lymphoma
-
Yuji K, Miyakoshi S, Kato D, Miura Y, Myojo T, Murashige N, et al. Reduced-intensity unrelated cord blood transplantation for patients with advanced malignant lymphoma. Biol Blood Marrow Transplant. 2005;11(4):314-8.
-
(2005)
Biol Blood Marrow Transplant.
, vol.11
, Issue.4
, pp. 314-318
-
-
Yuji, K.1
Miyakoshi, S.2
Kato, D.3
Miura, Y.4
Myojo, T.5
Murashige, N.6
-
40
-
-
33646430826
-
Comparable results of umbilical cord blood and HLAmatched sibling donor hematopoietic stem cell transplantation after reduced-intensity preparative regimen for advanced Hodgkin lymphoma
-
Majhail NS, Weisdorf DJ, Wagner JE, Defor TE, Brunstein CG, Burns LJ. Comparable results of umbilical cord blood and HLAmatched sibling donor hematopoietic stem cell transplantation after reduced-intensity preparative regimen for advanced Hodgkin lymphoma. Blood. 2006;107(9):3804-7.
-
(2006)
Blood
, vol.107
, Issue.9
, pp. 3804-3807
-
-
Majhail, N.S.1
Weisdorf, D.J.2
Wagner, J.E.3
Defor, T.E.4
Brunstein, C.G.5
Burns, L.J.6
-
41
-
-
58249136626
-
Promising progression-free survival for patients low and intermediate grade lymphoid malignancies after nonmyeloablative umbilical cord blood transplantation
-
Brunstein CG, Cantero S, Cao Q, Majhail N, McClune B, Burns LJ, et al. Promising progression-free survival for patients low and intermediate grade lymphoid malignancies after nonmyeloablative umbilical cord blood transplantation. Biol Blood Marrow Transplant. 2009;15(2):214-22.
-
(2009)
Biol Blood Marrow Transplant.
, vol.15
, Issue.2
, pp. 214-222
-
-
Brunstein, C.G.1
Cantero, S.2
Cao, Q.3
Majhail, N.4
McClune, B.5
Burns, L.J.6
-
42
-
-
78649429727
-
Reduced mortality after allogeneic hematopoietic-cell transplantation
-
Gooley TA, Chien JW, Pergam SA, Hingorani S, Sorror ML, Boeckh M, et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med. 2010;363(22):2091-101.
-
(2010)
N Engl J Med.
, vol.363
, Issue.22
, pp. 2091-2101
-
-
Gooley, T.A.1
Chien, J.W.2
Pergam, S.A.3
Hingorani, S.4
Sorror, M.L.5
Boeckh, M.6
-
43
-
-
79954441806
-
Allogeneic stem-cell transplantation as salvage therapy for patients with diffuse large B-cell non-Hodgkin's lymphoma relapsing after an autologous stem-cell transplantation: An analysis of the European Group for Blood and Marrow Transplantation Registry
-
van Kampen RJ, Canals C, Schouten HC, Nagler A, Thomson KJ, Vernant JP, et al. Allogeneic stem-cell transplantation as salvage therapy for patients with diffuse large B-cell non-Hodgkin's lymphoma relapsing after an autologous stem-cell transplantation: an analysis of the European Group for Blood and Marrow Transplantation Registry. J Clin Oncol. 2011;29(10):1342-8.
-
(2011)
J Clin Oncol.
, vol.29
, Issue.10
, pp. 1342-1348
-
-
van Kampen, R.J.1
Canals, C.2
Schouten, H.C.3
Nagler, A.4
Thomson, K.J.5
Vernant, J.P.6
-
44
-
-
84862513845
-
Reduced-intensity conditioning transplantation in acute leukemia: The effect of source of unrelated donor stem cells on outcomes
-
Brunstein CG, Eapen M, Ahn KW, Appelbaum FR, Ballen KK, Champlin RE, et al. Reduced-intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomes. Blood. 2012;119(23):5591-8.
-
(2012)
Blood
, vol.119
, Issue.23
, pp. 5591-5598
-
-
Brunstein, C.G.1
Eapen, M.2
Ahn, K.W.3
Appelbaum, F.R.4
Ballen, K.K.5
Champlin, R.E.6
-
45
-
-
77954031042
-
Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: A retrospective analysis
-
Eapen M, Rocha V, Sanz G, Scaradavou A, Zhang MJ, Arcese W, et al. Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis. Lancet Oncol. 2010;11(7):653-60.
-
(2010)
Lancet Oncol.
, vol.11
, Issue.7
, pp. 653-660
-
-
Eapen, M.1
Rocha, V.2
Sanz, G.3
Scaradavou, A.4
Zhang, M.J.5
Arcese, W.6
-
46
-
-
0029029246
-
1994 Consensus Conference on Acute GVHD Grading
-
Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, Thomas ED. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant. 1995;15(6):825-8.
-
(1995)
Bone Marrow Transplant.
, vol.15
, Issue.6
, pp. 825-828
-
-
Przepiorka, D.1
Weisdorf, D.2
Martin, P.3
Klingemann, H.G.4
Beatty, P.5
Hows, J.6
Thomas, E.D.7
-
47
-
-
78649462137
-
Allogeneic hematopoietic cell transplantation for hematologic malignancy: Relative risks and benefits of double umbilical cord blood
-
Brunstein CG, Gutman JA, Weisdorf DJ, Woolfrey AE, Defor TE, Gooley TA, et al. Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood. Blood. 2010;116(22):4693-9.
-
(2010)
Blood
, vol.116
, Issue.22
, pp. 4693-4699
-
-
Brunstein, C.G.1
Gutman, J.A.2
Weisdorf, D.J.3
Woolfrey, A.E.4
Defor, T.E.5
Gooley, T.A.6
|